These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 8546482

  • 1. Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications.
    Wasik MA, Vonderheid EC, Bigler RD, Marti R, Lessin SR, Polansky M, Kadin ME.
    Arch Dermatol; 1996 Jan; 132(1):42-7. PubMed ID: 8546482
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.
    Wasik MA, Sioutos N, Tuttle M, Butmarc JR, Kaplan WD, Kadin ME.
    Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma.
    Duvic M, Apisarnthanarax N, Cohen DS, Smith TL, Ha CS, Kurzrock R.
    J Am Acad Dermatol; 2003 Jul; 49(1):35-49. PubMed ID: 12833006
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W, Chyczewska E, Kovalchuk O, Tałałaj J, Izycki T, Panek B.
    Rocz Akad Med Bialymst; 2004 Jul; 49():246-51. PubMed ID: 15631351
    [Abstract] [Full Text] [Related]

  • 14. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
    Oka M, Hazama S, Takahashi M, Yamamoto K, Abe T, Yoshino S, Hayashi H, Tangoku A.
    Hepatogastroenterology; 1999 Jul; 46(28):2254-9. PubMed ID: 10521976
    [Abstract] [Full Text] [Related]

  • 15. Erythrodermic cutaneous T-cell lymphoma: how to differentiate this rare disease from atopic dermatitis.
    Miyagaki T, Sugaya M.
    J Dermatol Sci; 2011 Oct; 64(1):1-6. PubMed ID: 21872448
    [Abstract] [Full Text] [Related]

  • 16. [Usefulness of the measurement of serum soluble IL-2 receptor alpha chain levels in clinical monitoring of non-Hodgkin lymphoma].
    Setoyama Y, Imai J, Ishikawa T, Sakaida H, Takaori-Kondo A, Kawamata S, Uchiyama T.
    Rinsho Byori; 1994 Aug; 42(8):834-42. PubMed ID: 7933620
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of serum biological markers in patients with hepatocellular carcinoma.
    Parasole R, Izzo F, Perrone F, Pignata S, Galati MG, Leonardi E, Castiglione F, Orlando R, Castello G, Esposito G, Gallo C, Daniele B.
    Clin Cancer Res; 2001 Nov; 7(11):3504-9. PubMed ID: 11705869
    [Abstract] [Full Text] [Related]

  • 18. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
    Gadducci A, Ferdeghini M, Malagnino G, Prontera C, Fanucchi A, Annicchiarico C, Bianchi R, Fioretti P, Facchini V.
    Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
    [Abstract] [Full Text] [Related]

  • 19. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
    Boyano MD, Garcia-Vázquez MD, López-Michelena T, Gardeazabal J, Bilbao J, Cañavate ML, Galdeano AG, Izu R, Díaz-Ramón L, Raton JA, Díaz-Pérez JL.
    Br J Cancer; 2000 Oct; 83(7):847-52. PubMed ID: 10970683
    [Abstract] [Full Text] [Related]

  • 20. [Significance of soluble interleukin-2 receptor alpha chain in the management of patients with malignant lymphoma: a multi-center study].
    Ohno H, Ishikawa T, Kitajima H, Nomura S, Suzuki T, Konishi H, Ohno Y, Onishi R, Konaka Y, Arima N, Doi S, Nasu K, Takahashi T, Tsudo M, Fukuhara S, Uchiyama T.
    Rinsho Ketsueki; 2002 Mar; 43(3):170-5. PubMed ID: 11979748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.